Related content

Evaluation of N ^ε-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy

By Zhang X.   Lai Y.   McCance D.   Uchida K.   McDonald D.   Gardiner T.   Stitt A.   Curtis T.  

Diabetologia, Vol. 51, Iss. 9, 2008-09 ,pp. : 1723-1730

Springer Publishing Company

Access to resources Recommend Favorite

Nε-(Carboxymethyl)Lysine, a Major Advanced Glycation End Product in Exhaled Breath Condensate as a Biomarker of Small Airway Involvement in Asthma

By Tochino Yoshihiro   Kanazawa Hiroshi   Ichimaru Yukikazu   Asai Kazuhisa   Kyoh Shigenori   Hirata Kazuto  

Journal of Asthma, Vol. 44, Iss. 10, 2007-12 ,pp. : 861-866

Informa Healthcare

Access to resources Recommend Favorite

Olmesartan Medoxomil Is Associated with Decreased Plasma AGEs, Pentosidine, and N-(Epsilon)-Carboxymethyl-Lysine Levels in Hemodialysis Patients

By Honda Hirokazu   Hosaka Nozomu   Aoshima Yumie   Hirai Yuki   Michihata Tetsuo   Akizawa Tadao  

Clinical and Experimental Hypertension, Vol. 34, Iss. 1, 2012-02 ,pp. : 17-23

Informa Healthcare

Access to resources Recommend Favorite

Pegaptanib Sodium for the Treatment of Proliferative Diabetic Retinopathy and Diabetic Macular Edema

By  

Current Diabetes Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 33-38

Bentham Science Publishers

Access to resources Recommend Favorite

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes

By Tan K.   Shiu S.   Chow W.   Leng L.   Bucala R.   Betteridge D.  

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2756-2762

Springer Publishing Company

Access to resources Recommend Favorite